請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/36309完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳青周 | |
| dc.contributor.author | Chia-Wei Chou | en |
| dc.contributor.author | 周家瑋 | zh_TW |
| dc.date.accessioned | 2021-06-13T07:56:37Z | - |
| dc.date.available | 2005-08-12 | |
| dc.date.copyright | 2005-08-12 | |
| dc.date.issued | 2005 | |
| dc.date.submitted | 2005-07-22 | |
| dc.identifier.citation | Akira, S. (1997). Il-6-regulated transcription factors. Int J Biochem Cell Biol, 29(12), 1401-1418.
Amin, A. R., Attur, M., Patel, R. N., Thakker, G. D., Marshall, P. J., Rediske, J., et al. (1997). Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest, 99(6), 1231-1237. Anderson, G. D., Hauser, S. D., McGarity, K. L., Bremer, M. E., Isakson, P. C., & Gregory, S. A. (1996). Selective inhibition of cyclooxygenase (cox)-2 reverses inflammation and expression of cox-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest, 97(11), 2672-2679. Angel, P., & Karin, M. (1991). The role of jun, fos and the ap-1 complex in cell-proliferation and transformation. Biochim Biophys Acta, 1072(2-3), 129-157. Anwar, K. N., Fazal, F., Malik, A. B., & Rahman, A. (2004). Rhoa/rho-associated kinase pathway selectively regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via activation of i kappa b kinase beta and phosphorylation of rela/p65. J Immunol, 173(11), 6965-6972. Arenzana-Seisdedos, F., Turpin, P., Rodriguez, M., Thomas, D., Hay, R. T., Virelizier, J. L., et al. (1997). Nuclear localization of i kappa b alpha promotes active transport of nf-kappa b from the nucleus to the cytoplasm. J Cell Sci, 110 (Pt 3), 369-378. Asaka, M., Kimura, T., Kudo, M., Takeda, H., Mitani, S., Miyazaki, T., et al. (1992). Relationship of helicobacter pylori to serum pepsinogens in an asymptomatic japanese population. Gastroenterology, 102(3), 760-766. Attiga, F. A., Fernandez, P. M., Weeraratna, A. T., Manyak, M. J., & Patierno, S. R. (2000). Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res, 60(16), 4629-4637. Basak, C., Pathak, S. K., Bhattacharyya, A., Mandal, D., Pathak, S., & Kundu, M. (2005). Nf-kappab- and c/ebpbeta-driven interleukin-1beta gene expression and pak1-mediated caspase-1 activation play essential roles in interleukin-1beta release from helicobacter pylori lipopolysaccharide-stimulated macrophages. J Biol Chem, 280(6), 4279-4288. Bernstein, L. R., & Colburn, N. H. (1989). Ap1/jun function is differentially induced in promotion-sensitive and resistant jb6 cells. Science, 244(4904), 566-569. Blaser, M. J. (1992). Helicobacter pylori: Its role in disease. Clin Infect Dis, 15(3), 386-391. Blaser, M. J. (1993). Helicobacter pylori: Microbiology of a 'slow' bacterial infection. Trends Microbiol, 1(7), 255-260. Bradley, M. N., Zhou, L., & Smale, S. T. (2003). C/ebpbeta regulation in lipopolysaccharide-stimulated macrophages. Mol Cell Biol, 23(14), 4841-4858. Byers, S. W., Sommers, C. L., Hoxter, B., Mercurio, A. M., & Tozeren, A. (1995). Role of e-cadherin in the response of tumor cell aggregates to lymphatic, venous and arterial flow: Measurement of cell-cell adhesion strength. J Cell Sci, 108 (Pt 5), 2053-2064. Cashman, J., & McAnulty, G. (1995). Nonsteroidal anti-inflammatory drugs in perisurgical pain management. Mechanisms of action and rationale for optimum use. Drugs, 49(1), 51-70. Cashman, J. N. (1996). The mechanisms of action of nsaids in analgesia. Drugs, 52 Suppl 5, 13-23. Cassel, T. N., & Nord, M. (2003). C/ebp transcription factors in the lung epithelium. Am J Physiol Lung Cell Mol Physiol, 285(4), L773-781. Castelao, J. E., Bart, R. D., 3rd, DiPerna, C. A., Sievers, E. M., & Bremner, R. M. (2003). Lung cancer and cyclooxygenase-2. Ann Thorac Surg, 76(4), 1327-1335. Censini, S., Lange, C., Xiang, Z., Crabtree, J. E., Ghiara, P., Borodovsky, M., et al. (1996). Cag, a pathogenicity island of helicobacter pylori, encodes type i-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A, 93(25), 14648-14653. Chang, Y. J., Wu, M. S., Lin, J. T., Sheu, B. S., Muta, T., Inoue, H., et al. (2004). Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by helicobacter pylori involves tlr2/tlr9 and c-src-dependent nuclear factor-kappab activation. Mol Pharmacol, 66(6), 1465-1477. Chen, C. C., Sun, Y. T., Chen, J. J., & Chiu, K. T. (2000). Tnf-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: Involvement of the phospholipase c-gamma 2, protein kinase c-alpha, tyrosine kinase, nf-kappa b-inducing kinase, and i-kappa b kinase 1/2 pathway. J Immunol, 165(5), 2719-2728. Chen, F. E., Huang, D. B., Chen, Y. Q., & Ghosh, G. (1998). Crystal structure of p50/p65 heterodimer of transcription factor nf-kappab bound to DNA. Nature, 391(6665), 410-413. Chen, L. F., & Greene, W. C. (2004). Shaping the nuclear action of nf-kappab. Nat Rev Mol Cell Biol, 5(5), 392-401. Cherng, C. H., Wong, C. S., & Ho, S. T. (1996). Spinal actions of nonsteroidal anti-inflammatory drugs. Acta Anaesthesiol Sin, 34(2), 81-88. Cho, M. K., & Kim, S. G. (2003). Hepatocyte growth factor activates ccaat enhancer binding protein and cell replication via pi3-kinase pathway. Hepatology, 37(3), 686-695. Chun, K. S., & Surh, Y. J. (2004). Signal transduction pathways regulating cyclooxygenase-2 expression: Potential molecular targets for chemoprevention. Biochem Pharmacol, 68(6), 1089-1100. Churin, Y., Kardalinou, E., Meyer, T. F., & Naumann, M. (2001). Pathogenicity island-dependent activation of rho gtpases rac1 and cdc42 in helicobacter pylori infection. Mol Microbiol, 40(4), 815-823. Cieslik, K. A., Zhu, Y., Shtivelband, M., & Wu, K. K. (2005). Inhibition of p90 ribosomal s6 kinase-mediated ccaat/enhancer-binding protein beta activation and cyclooxygenase-2 expression by salicylate. J Biol Chem, 280(18), 18411-18417.Correa, P., Fox, J., Fontham, E., Ruiz, B., Lin, Y. P., Zavala, D., et al. (1990). Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer, 66(12), 2569-2574. Coyne, D. W., Nickols, M., Bertrand, W., & Morrison, A. R. (1992). Regulation of mesangial cell cyclooxygenase synthesis by cytokines and glucocorticoids. Am J Physiol, 263(1 Pt 2), F97-102. Craanen, M. E., Dekker, W., Blok, P., Ferwerda, J., & Tytgat, G. N. (1992). Intestinal metaplasia and helicobacter pylori: An endoscopic bioptic study of the gastric antrum. Gut, 33(1), 16-20. Cramer, P., & Muller, C. W. (1999). A firm hand on nfkappab: Structures of the ikappabalpha-nfkappab complex. Structure Fold Des, 7(1), R1-6. Crofford, L. J. (1997). Cox-1 and cox-2 tissue expression: Implications and predictions. J Rheumatol Suppl, 49, 15-19. Delhase, M., Li, N., & Karin, M. (2000). Kinase regulation in inflammatory response. Nature, 406(6794), 367-368. Dempke, W., Rie, C., Grothey, A., & Schmoll, H. J. (2001). Cyclooxygenase-2: A novel target for cancer chemotherapy? J Cancer Res Clin Oncol, 127(7), 411-417. Dong, Z., Huang, C., Brown, R. E., & Ma, W. Y. (1997). Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J Biol Chem, 272(15), 9962-9970. DuBois, R. N., Giardiello, F. M., & Smalley, W. E. (1996). Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. Gastroenterol Clin North Am, 25(4), 773-791. Eferl, R., & Wagner, E. F. (2003). Ap-1: A double-edged sword in tumorigenesis. Nat Rev Cancer, 3(11), 859-868. Fennerty, M. B., Emerson, J. C., Sampliner, R. E., McGee, D. L., Hixson, L. J., & Garewal, H. S. (1992). Gastric intestinal metaplasia in ethnic groups in the southwestern united states. Cancer Epidemiol Biomarkers Prev, 1(4), 293-296. Fosslien, E. (2000). Biochemistry of cyclooxygenase (cox)-2 inhibitors and molecular pathology of cox-2 in neoplasia. Crit Rev Clin Lab Sci, 37(5), 431-502. Fox, J. G., Correa, P., Taylor, N. S., Thompson, N., Fontham, E., Janney, F., et al. (1992). High prevalence and persistence of cytotoxin-positive helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol, 87(11), 1554-1560. Fu, J. Y., Masferrer, J. L., Seibert, K., Raz, A., & Needleman, P. (1990). The induction and suppression of prostaglandin h2 synthase (cyclooxygenase) in human monocytes. J Biol Chem, 265(28), 16737-16740. Garg, A., & Aggarwal, B. B. (2002). Nuclear transcription factor-kappab as a target for cancer drug development. Leukemia, 16(6), 1053-1068. Gately, S. (2000). The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev, 19(1-2), 19-27. Geng, Y., Blanco, F. J., Cornelisson, M., & Lotz, M. (1995). Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J Immunol, 155(2), 796-801. Ghoda, L., Lin, X., & Greene, W. C. (1997). The 90-kda ribosomal s6 kinase (pp90rsk) phosphorylates the n-terminal regulatory domain of ikappabalpha and stimulates its degradation in vitro. J Biol Chem, 272(34), 21281-21288. Graham, D. Y., Lew, G. M., Klein, P. D., Evans, D. G., Evans, D. J., Jr., Saeed, Z. A., et al. (1992). Effect of treatment of helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med, 116(9), 705-708. Guarner, J., Mohar, A., Parsonnet, J., & Halperin, D. (1993). The association of helicobacter pylori with gastric cancer and preneoplastic gastric lesions in chiapas, mexico. Cancer, 71(2), 297-301. Haas, R., Meyer, T. F., & van Putten, J. P. (1993). Aflagellated mutants of helicobacter pylori generated by genetic transformation of naturally competent strains using transposon shuttle mutagenesis. Mol Microbiol, 8(4), 753-760. Halliday, G., Robinson, S. R., Shepherd, C., & Kril, J. (2000). Alzheimer's disease and inflammation: A review of cellular and therapeutic mechanisms. Clin Exp Pharmacol Physiol, 27(1-2), 1-8. Hao, X., Bishop, A. E., Wallace, M., Wang, H., Willcocks, T. C., Maclouf, J., et al. (1999). Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. J Pathol, 187(3), 295-301. Hatada, E. N., Krappmann, D., & Scheidereit, C. (2000). Nf-kappab and the innate immune response. Curr Opin Immunol, 12(1), 52-58. Hatakeyama, M. (2004). Oncogenic mechanisms of the helicobacter pylori caga protein. Nat Rev Cancer, 4(9), 688-694. Hazell, S. L., Lee, A., Brady, L., & Hennessy, W. (1986). Campylobacter pyloridis and gastritis: Association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis, 153(4), 658-663. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., et al. (1998). Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res, 58(17), 3761-3764. Hirata, Y., Maeda, S., Mitsuno, Y., Akanuma, M., Yamaji, Y., Ogura, K., et al. (2001). Helicobacter pylori activates the cyclin d1 gene through mitogen-activated protein kinase pathway in gastric cancer cells. Infect Immun, 69(6), 3965-3971. Hotchin, N. A., Cover, T. L., & Akhtar, N. (2000). Cell vacuolation induced by the vaca cytotoxin of helicobacter pylori is regulated by the rac1 gtpase. J Biol Chem, 275(19), 14009-14012. Huang, S., Chen, L. Y., Zuraw, B. L., Ye, R. D., & Pan, Z. K. (2001). Chemoattractant-stimulated nf-kappab activation is dependent on the low molecular weight GTPase RhoA. J Biol Chem, 276(44), 40977-40981. Huang, W.C. & Chen, C.C. (2005). Akt Phosphorylation of p300 at Ser-1834 Is Essential for Its Histone Acetyltransferase and Transcriptional Activity. Mol Cell Biol, 2005 25(15),6592-602. Hull, M., Lieb, K., & Fiebich, B. L. (2000). Anti-inflammatory drugs: A hope for alzheimer's disease? Expert Opin Investig Drugs, 9(4), 671-683. Johnson, P. F., & McKnight, S. L. (1989). Eukaryotic transcriptional regulatory proteins. Annu Rev Biochem, 58, 799-839. Juttner, S., Cramer, T., Wessler, S., Walduck, A., Gao, F., Schmitz, F., et al. (2003). Helicobacter pylori stimulates host cyclooxygenase-2 gene transcription: Critical importance of mek/erk-dependent activation of usf1/-2 and creb transcription factors. Cell Microbiol, 5(11), 821-834. Kang, R. Y., Freire-Moar, J., Sigal, E., & Chu, C. Q. (1996). Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br J Rheumatol, 35(8), 711-718. Karim, S., Habib, A., Levy-Toledano, S., & Maclouf, J. (1996). Cyclooxygenase-1 and -2 of endothelial cells utilize exogenous or endogenous arachidonic acid for transcellular production of thromboxane. J Biol Chem, 271(20), 12042-12048. Kawahara, T., Kohjima, M., Kuwano, Y., Mino, H., Teshima-Kondo, S., Takeya, R., et al. (2005). Helicobacter pylori lipopolysaccharide activates rac1 and transcription of nadph oxidase nox1 and its organizer noxo1 in guinea pig gastric mucosal cells. Am J Physiol Cell Physiol, 288(2), C450-457. Keates, S., Keates, A. C., Warny, M., Peek, R. M., Jr., Murray, P. G., & Kelly, C. P. (1999). Differential activation of mitogen-activated protein kinases in ags gastric epithelial cells by cag+ and cag- helicobacter pylori. J Immunol, 163(10), 5552-5559. Kim, H., Lim, J. W., & Kim, K. H. (2001). Helicobacter pylori-induced expression of interleukin-8 and cyclooxygenase-2 in ags gastric epithelial cells: Mediation by nuclear factor-kappab. Scand J Gastroenterol, 36(7), 706-716. Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988). The leucine zipper: A hypothetical structure common to a new class of DNA binding proteins. Science, 240(4860), 1759-1764. Lee, S. H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., et al. (1992). Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem, 267(36), 25934-25938. Lekstrom-Himes, J., & Xanthopoulos, K. G. (1998). Biological role of the ccaat/enhancer-binding protein family of transcription factors. J Biol Chem, 273(44), 28545-28548. Leying, H., Suerbaum, S., Geis, G., & Haas, R. (1992). Cloning and genetic characterization of a helicobacter pylori flagellin gene. Mol Microbiol, 6(19), 2863-2874. Li, Q., & Verma, I. M. (2002). Nf-kappab regulation in the immune system. Nat Rev Immunol, 2(10), 725-734. Lukiw, W. J., & Bazan, N. G. (2000). Neuroinflammatory signaling upregulation in alzheimer's disease. Neurochem Res, 25(9-10), 1173-1184. Maeda, S., Akanuma, M., Mitsuno, Y., Hirata, Y., Ogura, K., Yoshida, H., et al. (2001). Distinct mechanism of helicobacter pylori-mediated nf-kappa b activation between gastric cancer cells and monocytic cells. J Biol Chem, 276(48), 44856-44864. Malaty, H. M., Evans, D. G., Evans, D. J., Jr., & Graham, D. Y. (1992). Helicobacter pylori in hispanics: Comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology, 103(3), 813-816. Marnett, L. J., & DuBois, R. N. (2002). Cox-2: A target for colon cancer prevention. Annu Rev Pharmacol Toxicol, 42, 55-80. Marshall, B. J., & Warren, J. R. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 1(8390), 1311-1315. Masamune, A., Shimosegawa, T., Masamune, O., Mukaida, N., Koizumi, M., & Toyota, T. (1999). Helicobacter pylori-dependent ceramide production may mediate increased interleukin 8 expression in human gastric cancer cell lines. Gastroenterology, 116(6), 1330-1341. Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., et al. (2000). Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res, 60(5), 1306-1311. May, M. J., D'Acquisto, F., Madge, L. A., Glockner, J., Pober, J. S., & Ghosh, S. (2000). Selective inhibition of nf-kappab activation by a peptide that blocks the interaction of nemo with the ikappab kinase complex. Science, 289(5484), 1550-1554. Meyer-ter-Vehn, T., Covacci, A., Kist, M., & Pahl, H. L. (2000). Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem, 275(21), 16064-16072. Mitsuno, Y., Yoshida, H., Maeda, S., Ogura, K., Hirata, Y., Kawabe, T., et al. (2001). Helicobacter pylori induced transactivation of sre and ap-1 through the erk signalling pathway in gastric cancer cells. Gut, 49(1), 18-22. Montecucco, C., & Rappuoli, R. (2001). Living dangerously: How helicobacter pylori survives in the human stomach. Nat Rev Mol Cell Biol, 2(6), 457-466. Mori, N., Krensky, A. M., Geleziunas, R., Wada, A., Hirayama, T., Sasakawa, C., et al. (2003). Helicobacter pylori induces rantes through activation of nf-kappa b. Infect Immun, 71(7), 3748-3756. Naumann, M., Wessler, S., Bartsch, C., Wieland, B., Covacci, A., Haas, R., et al. (1999). Activation of activator protein 1 and stress response kinases in epithelial cells colonized by helicobacter pylori encoding the cag pathogenicity island. J Biol Chem, 274(44), 31655-31662. Nomura, A., Stemmermann, G. N., Chyou, P. H., Kato, I., Perez-Perez, G. I., & Blaser, M. J. (1991). Helicobacter pylori infection and gastric carcinoma among japanese americans in hawaii. N Engl J Med, 325(16), 1132-1136. Ozes, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., & Donner, D. B. (1999). Nf-kappab activation by tumour necrosis factor requires the akt serine-threonine kinase. Nature, 401(6748), 82-85. Pairet, M., & Engelhardt, G. (1996). Distinct isoforms (cox-1 and cox-2) of cyclooxygenase: Possible physiological and therapeutic implications. Fundam Clin Pharmacol, 10(1), 1-17. Palovuori, R., Perttu, A., Yan, Y., Karttunen, R., Eskelinen, S., & Karttunen, T. J. (2000). Helicobacter pylori induces formation of stress fibers and membrane ruffles in ags cells by rac activation. Biochem Biophys Res Commun, 269(1), 247-253. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., et al. (1991). Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med, 325(16), 1127-1131. Peek, R. M., Jr., Vaezi, M. F., Falk, G. W., Goldblum, J. R., Perez-Perez, G. I., Richter, J. E., et al. (1999). Role of helicobacter pylori caga(+) strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia. Int J Cancer, 82(4), 520-524. Piwien-Pilipuk, G., MacDougald, O., & Schwartz, J. (2002). Dual regulation of phosphorylation and dephosphorylation of c/ebpbeta modulate its transcriptional activation and DNA binding in response to growth hormone. J Biol Chem, 277(46), 44557-44565. Pomorski, T., Meyer, T. F., & Naumann, M. (2001). Helicobacter pylori-induced prostaglandin e(2) synthesis involves activation of cytosolic phospholipase a(2) in epithelial cells. J Biol Chem, 276(1), 804-810. Ramji, D. P., & Foka, P. (2002). Ccaat/enhancer-binding proteins: Structure, function and regulation. Biochem J, 365(Pt 3), 561-575. Riento, K., & Ridley, A. J. (2003). Rocks: Multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol, 4(6), 446-456. Ristimaki, A., Honkanen, N., Jankala, H., Sipponen, P., & Harkonen, M. (1997). Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res, 57(7), 1276-1280. Roggero, E., Zucca, E., Pinotti, G., Pascarella, A., Capella, C., Savio, A., et al. (1995). Eradication of helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med, 122(10), 767-769. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., et al. (1995). Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res, 55(17), 3785-3789. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer, 2(2): 133-142,2002 Scherer, D. C., Brockman, J. A., Chen, Z., Maniatis, T., & Ballard, D. W. (1995). Signal-induced degradation of i kappa b alpha requires site-specific ubiquitination. Proc Natl Acad Sci U S A, 92(24), 11259-11263. Sekine, O., Nishio, Y., Egawa, K., Nakamura, T., Maegawa, H., & Kashiwagi, A. (2002). Insulin activates ccaat/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. J Biol Chem, 277(39), 36631-36639. Seo, J. H., Lim, J. W., Kim, H., & Kim, K. H. (2004). Helicobacter pylori in a korean isolate activates mitogen-activated protein kinases, ap-1, and nf-kappab and induces chemokine expression in gastric epithelial ags cells. Lab Invest, 84(1), 49-62. Smith, M. F., Jr., Mitchell, A., Li, G., Ding, S., Fitzmaurice, A. M., Ryan, K., et al. (2003). Toll-like receptor (tlr) 2 and tlr5, but not tlr4, are required for helicobacter pylori-induced nf-kappa b activation and chemokine expression by epithelial cells. J Biol Chem, 278(35), 32552-32560. Stancovski, I., & Baltimore, D. (1997). Nf-kappab activation: The i kappab kinase revealed? Cell, 91(3), 299-302. Tazawa, R., Xu, X. M., Wu, K. K., & Wang, L. H. (1994). Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin h synthase-2 gene. Biochem Biophys Res Commun, 203(1), 190-199. Thomas, B., Berenbaum, F., Humbert, L., Bian, H., Bereziat, G., Crofford, L., et al. (2000). Critical role of c/ebpdelta and c/ebpbeta factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1beta in articular chondrocytes. Eur J Biochem, 267(23), 6798-6809. Toker, A., & Newton, A. C. (2000). Cellular signaling: Pivoting around pdk-1. Cell, 103(2), 185-188. Tompkins, L. S., & Falkow, S. (1995). The new path to preventing ulcers. Science, 267(5204), 1621-1622. Tsujii, M., & DuBois, R. N. (1995). Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83(3), 493-501. Tsujii, M., Kawano, S., & DuBois, R. N. (1997). Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A, 94(7), 3336-3340. Turini, M. E., & DuBois, R. N. (2002). Cyclooxygenase-2: A therapeutic target. Annu Rev Med, 53, 35-57. Varro, A., Noble, P. J., Pritchard, D. M., Kennedy, S., Hart, C. A., Dimaline, R., et al. (2004). Helicobacter pylori induces plasminogen activator inhibitor 2 in gastric epithelial cells through nuclear factor-kappab and rhoa: Implications for invasion and apoptosis Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998). Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol, 38, 97-120. Viatour, P., Merville, M. P., Bours, V., & Chariot, A. (2005). Phosphorylation of nf-kappab and ikappab proteins: Implications in cancer and inflammation. Trends Biochem Sci, 30(1), 43-52. Vinson, C. R., Sigler, P. B., & McKnight, S. L. (1989). Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science, 246(4932), 911-916. Wessler, S., Hocker, M., Fischer, W., Wang, T. C., Rosewicz, S., Haas, R., et al. (2000). Helicobacter pylori activates the histidine decarboxylase promoter through a mitogen-activated protein kinase pathway independent of pathogenicity island-encoded virulence factors. J Biol Chem, 275(5), 3629-3636. Wessler, S., Rapp, U. R., Wiedenmann, B., Meyer, T. F., Schoneberg, T., Hocker, M., et al. (2002). B-raf/rap1 signaling, but not c-raf-1/ras, induces the histidine decarboxylase promoter in helicobacter pylori infection. Faseb J, 16(3), 417-419. Williams, C. S., Mann, M., & DuBois, R. N. (1999). The role of cyclooxygenases in inflammation, cancer, and development. Oncogene, 18(55), 7908-7916. Williams, S. C., Baer, M., Dillner, A. J., & Johnson, P. F. (1995). Crp2 (c/ebp beta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. Embo J, 14(13), 3170-3183. Wotherspoon, A. C., Doglioni, C., Diss, T. C., Pan, L., Moschini, A., de Boni, M., et al. (1993). Regression of primary low-grade b-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of helicobacter pylori. Lancet, 342(8871), 575-577. Wroblewski, L. E., Noble, P. J., Pagliocca, A., Pritchard, D. M., Hart, C. A., Campbell, F., et al. (2003). Stimulation of mmp-7 (matrilysin) by helicobacter pylori in human gastric epithelial cells: Role in epithelial cell migration. J Cell Sci, 116(Pt 14), 3017-3026. Wyatt, J. I., Shallcross, T. M., Crabtree, J. E., & Heatley, R. V. (1992). Helicobacter pylori, gastritis, and peptic ulceration in the elderly. J Clin Pathol, 45(12), 1070-1074. Yaron, A., Gonen, H., Alkalay, I., Hatzubai, A., Jung, S., Beyth, S., et al. (1997). Inhibition of nf-kappa-b cellular function via specific targeting of the i-kappa-b-ubiquitin ligase. Embo J, 16(21), 6486-6494. Zhu, Y., Saunders, M. A., Yeh, H., Deng, W. G., & Wu, K. K. (2002). Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms of ccaat/enhancer-binding proteins. J Biol Chem, 277(9), 6923-6928. Zimmermann, K. C., Sarbia, M., Weber, A. A., Borchard, F., Gabbert, H. E., & Schror, K. (1999). Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res, 59(1), 198-204. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/36309 | - |
| dc.description.abstract | 幽門螺旋桿菌屬格蘭氏陰性微耗氧菌，與慢性胃炎、消化性潰瘍及胃癌的發生有關。流行病學研究顯示，胃癌、幽門螺旋桿菌與第二型環氧化酶具高度關連性，而本實驗室先前之研究亦發現，胃癌病人分離出之幽門螺旋桿菌誘發胃上皮細胞表現較多第二型環氧化酶，而H. pylori活化COX-2之promoter需 κB、NF-IL6與CRE這些cis-elements之參與，且TLR2/9、PI-PLC/PKC/c-Src或MAPKs參與其訊息傳遞路徑。因此本論文進一步釐清H. pylori誘發COX-2表現之機制。我們發現，H. pylori可活化PI3K/Akt及RhoA/ROCK，並發現它們參與H. pylori誘發之COX-2表現。PI3K與ROCK之抑制劑可阻斷幽門螺旋桿菌誘發之COX-2表現及promoter活性， ROCK抑制劑可降低H. pylori活化之IKK和RSK-1，使IκBα免於分解，並降低核內之p65含量與活性。除了NF-κB外，H. pylori亦增加C/EBPβ和C/EBPδ結合至COX-2 promoter之NF-IL6 site，PI3K和ROCK亦參與此過程之調控，雖然它們不調控H. pylori引發之C/EBPβ Thr235磷酸化， RhoA/ROCK可能參與H. pylori誘發之C/EBPδ表現。本論文首次指出H. pylori可經由RhoA/ROCK路徑調控COX-2之表現，主要作用在NF-κB和NF-IL6 sites，ROCK經由活化IKK，增加p65之Ser536磷酸化，而調控NF-κB之活性；也增加C/EBPδ mRNA之表現量，而增加NF-IL6之活性。 | zh_TW |
| dc.description.abstract | Helicobacter pylori (H. pylori) is a Gram-negative microaerophilic bacterium that causes chronic gastritis, peptic ulcer, and gastric carcinoma. Epidemiological studies have shown the correlation between gastric cancer, H. pylori and COX-2. Our previous studies have shown that TLR2/TLR9 and PI-PLC/PKC/c-Src or MAPKs were involved in the H. pylori-induced COX-2 expression in AGS gastric epithelial cells. Since the κB、NF-IL6 and CRE sites were critical for H. pylori-induced COX-2 promoter activity, we further elucidated the mechanisms underlying the H. pylori-induced COX-2 expression. In this study, we demonstrated that RhoA/ROCK and PI3K/Akt were activated after H. pylori infection and participated in the H. pylori-induced COX-2 expression. Both pharmacological inhibitors of PI3K (LY294002) and ROCK (Y27632) could attenuate H. pylori-induced COX-2 expression and promoter activity. Y27632 inhibited the H. pylori-induced IKK and RSK-1 activity, IκBα degradation and nuclear p65 activity. By DAPA and ChIP, we demonstrated the in vitro and in vivo bindings of C/EBPβ and C/EBPδ to the COX-2 promoter induced by H. pylori. The binding processes were regulated by PI3K and ROCK, although they were irrelevant to H. pylori-induced C/EBPβ Thr235 phophorylation. Furthermore, H. pylori could induce C/EBPδ mRNA expression via RhoA/ROCK pathway. In summary, we are the first to report that RhoA/ROCK regulated the H. pylori-induced COX-2 expression via NF-κB and NF-IL6 sites. ROCK not only stimulated NF-κB by augmenting the phosphorylation of IKK and p65, but also activated NF-IL6 by increasing the C/EBPδ mRNA expression. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T07:56:37Z (GMT). No. of bitstreams: 1 ntu-94-R92443010-1.pdf: 3330250 bytes, checksum: bead016cad738365e791a2c8cee1efd8 (MD5) Previous issue date: 2005 | en |
| dc.description.tableofcontents | 縮寫表……………………………………………………………… 2
(Abbreviation) 中文摘要…………………………………………………………… 5 (Abstract in Chinese) 英文摘要…………………………………………………………… 6 (Abstract in English) 緒論………………………………………………………………… 7 (Introduction) 實驗材料與方法……………………………………………………36 (Materials and Methods) 結果…………………………………………………………………44 (Results) 討論…………………………………………………………………62 (Discussion) 參考文獻……………………………………………………………67 (References) | |
| dc.language.iso | zh-TW | |
| dc.title | 幽門螺旋桿菌在胃上皮細胞引發第二型環氧化酶表現之機轉~RhoA/ROCK和PI3K/Akt之作用探討~ | zh_TW |
| dc.title | Mechanism of Cyclooxygenase-2 Expression Induced by Helicobacter pylori in Human Gastric Epithelial Cells
~The Effects of RhoA/ROCK and PI3K/Akt~ | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 93-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 林肇堂,吳明賢 | |
| dc.subject.keyword | 幽門螺旋桿菌,第二型環氧化酶, | zh_TW |
| dc.subject.keyword | Helicobacter pylori,cyclooxygenase-2,RhoA,Rock,PI3K,Akt, | en |
| dc.relation.page | 79 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2005-07-25 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 藥理學研究所 | zh_TW |
| 顯示於系所單位： | 藥理學科所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-94-1.pdf 目前未授權公開取用 | 3.25 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。